Theriva Biologics, Inc. — Investor Relations & Filings
Filings indexed
1,020
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
TOVX
Theriva Biologics, Inc. is a clinical-stage immuno-oncology company developing a new class of oncolytic virus therapeutics. The company's platform is engineered for systemic delivery to overcome the protective barrier surrounding solid tumors. These developmental therapies are designed to selectively replicate within and kill tumor cells, with the potential to enhance current standard-of-care treatments. Theriva's lead candidates are being advanced to address a range of difficult-to-treat cancers and diseases in areas of high unmet medical need.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Theriva Biologics, Inc. (0000894158) (Filer) | 2026-05-05 | English | |
| 8-K - Theriva Biologics, Inc. (0000894158) (Filer) | 2026-05-05 | English | |
| DEF 14A | 2026-04-30 | English | |
| PRE 14A | 2026-04-20 | English | |
| FORM 8-K | 2026-04-17 | English | |
| FORM 8-K | 2026-04-09 | English |
Browse filings by year
31 years- 2026 19 filings
- 2025 60 filings
- 2024 47 filings
- 2023 32 filings
- 2022 53 filings
- 2021 59 filings
- 2020 31 filings
- 2019 29 filings
- 2018 53 filings
- 2017 41 filings
- 2016 34 filings
- 2015 62 filings
- 2014 34 filings
- 2013 49 filings
- 2012 76 filings
- 2011 37 filings
- 2010 42 filings
- 2009 33 filings
- 2008 35 filings
- 2007 55 filings
- 2006 26 filings
- 2005 17 filings
- 2004 1 filing
- 2003 9 filings
- 2002 9 filings
- 2001 15 filings
- 2000 6 filings
- 1999 16 filings
- 1998 14 filings
- 1997 20 filings
- 1996 6 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41533757 | 10-Q - Theriva Biologics, Inc. (0000894158) (Filer) | 2026-05-05 | English | ||
| 41531768 | 8-K - Theriva Biologics, Inc. (0000894158) (Filer) | 2026-05-05 | English | ||
| 46201037 | DEF 14A | 2026-04-30 | English | ||
| 46201038 | PRE 14A | 2026-04-20 | English | ||
| 46201039 | FORM 8-K | 2026-04-17 | English | ||
| 46201040 | FORM 8-K | 2026-04-09 | English | ||
| 33013154 | 8-K - Theriva Biologics, Inc. (0000894158) (Filer) | 2026-03-23 | English | ||
| 46201044 | DEF 14A | 2026-03-16 | English | ||
| 46201043 | 10-K | 2026-03-12 | English | ||
| 46201045 | FORM 8-K | 2026-03-12 | English | ||
| 46201046 | PRE 14A | 2026-03-04 | English | ||
| 32883382 | 8-K - THERIVA BIOLOGICS, INC. (0000894158) (Filer) | 2026-02-18 | English | ||
| 25289494 | 8-K Filing | 2026-02-12 | English | ||
| 25289629 | 8-K Filing | 2026-01-12 | English | ||
| 25289510 | 4 Filing | 2026-01-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Theriva Biologics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35456/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35456 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35456 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35456 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35456}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Theriva Biologics, Inc. (id: 35456)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.